SCHWARTZ BRIAN - Insider Non-Derivative Transactions at Cyclacel Pharmaceuticals, Inc. (CYCC) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 29, 2024, SCHWARTZ BRIAN's relationship to Cyclacel Pharmaceuticals, Inc. (CYCC) is Director,Officer (Interim Chief Medical Officer), and currently has 15,205 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CYCC insiders.
Data Source: SEC.
SCHWARTZ BRIAN - Insider Non-Derivative Transactions of CYCC Common Stock
SCHWARTZ BRIAN - Insider Non-Derivative Transactions at CYCC
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 30, 2024 | Acquisition -- (Common Stock) | 12500 | 0 | 15205 |
| Jul 1, 2023 | Acquisition -- (Common Stock) | 21219 | 0 | 40602 |